AS101 Prevents Diabetic Nephropathy Progression and Mesangial Cell Dysfunction: Regulation of the AKT Downstream Pathway

• Itay Israel Shemesh ,

  Contributed equally to this work with: Itay Israel Shemesh, Benaya Rozen-Zvi

  * E-mail: Benjamin.Sredni@biu.ac.il (BS); Itay.sh4@gmail.com (IIS)

  Affiliation Safdié Institute for AIDS and Immunology Research, The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel

  ⨯
• Benaya Rozen-Zvi ,

  Contributed equally to this work with: Itay Israel Shemesh, Benaya Rozen-Zvi

  Affiliations Department of Nephrology and Hypertension, Rabin Medical Center, Petah-Tikva, Israel, Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel

  ⨯
• Yona Kalechman,

  Affiliation Safdié Institute for AIDS and Immunology Research, The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel

  ⨯
• Uzi Gafter,

  Affiliations Department of Nephrology and Hypertension, Rabin Medical Center, Petah-Tikva, Israel, Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel

  ⨯
• Benjamin Sredni

  * E-mail: Benjamin.Sredni@biu.ac.il (BS); Itay.sh4@gmail.com (IIS)

  Affiliation Safdié Institute for AIDS and Immunology Research, The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel

  ⨯